Related Experiment Video
Updated: May 16, 2026

Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
TALENs: a widely applicable technology for targeted genome editing
J Keith Joung1, Jeffry D Sander
1Massachusetts General Hospital, Molecular Pathology Unit, the Center for Computational and Integrative Biology, and the Center for Cancer Research, Harvard Medical School, Department of Pathology, 149 13th Street, 6th floor, Charlestown, Massachusetts 02129, USA. jjoung@partners.org
Transcription activator-like effector nucleases (TALENs) offer precise gene editing across diverse organisms. This technology enables targeted gene alteration, advancing biological research and potential genetic disease therapies.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Engineered nucleases are powerful tools for targeted DNA modification.
- Developing customizable DNA-binding specificities is crucial for gene editing applications.
Purpose of the Study:
- To introduce and describe transcription activator-like effector nucleases (TALENs) as a novel gene editing technology.
- To highlight the potential of TALENs for targeting virtually any DNA sequence.
Main Methods:
- Fusion of a DNA-cleaving nuclease domain with an engineered DNA-binding domain (TAL effectors).
- Customizable design of TALENs to recognize specific DNA sequences.
Main Results:
- TALENs can be engineered to target essentially any desired DNA sequence.
- The technology allows for quick and efficient gene alteration.
Conclusions:
- TALENs represent a significant advancement in gene editing capabilities.
- This technology holds promise for transformative impacts in biological research and the development of genetic therapies.
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
CRISPR/Cas9 Genome Editing
CRISPR
Homologous Recombination
In-vitro Mutagenesis

